Semin Cancer Biol. 2018 Aug 3. pii: S1044-579X(18)30045-2. doi: 10.1016/j.semcancer.2018.08.002. [Epub ahead of print]

Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.

Zhao Y¹, Dong Q², Li J³, Zhang K², Qin J³, Zhao J⁴, Sun Q³, Wang Z³, Wartmann T⁵, Jauch KW⁶, Nelson PJ⁷, Qin L², Bruns C⁸.

Abstract

A small subpopulation of cells within the bulk of tumors share features with somatic stem cells, in that, they are capable of self-renewal, they differentiate, and are highly resistant to conventional therapy. These cells have been referred to as cancer stem cells (CSCs). Recent reports support the central importance of a cancer stem cell-like niche that appears to help foster the generation and maintenance of CSCs. In response to signals provided by this microenvironment, CSCs express the tumorigenic characteristics that can drive tumor metastasis by the induction of epithelial-mesenchymal-transition (EMT) that in turn fosters the migration and recolonization of the cells as secondary tumors within metastatic niches. We summarize here recent advances in cancer stem cell research including the characterization of their genetic and epigenetic features, metabolic specialities, and crosstalk with aging-associated processes. Potential strategies for targeting CSCs, and their niche, by regulating CSCs plasticity, or therapeutic sensitivity is discussed. Finally, it is hoped that new strategies and related therapeutic approaches as outlined here may help prevent the formation of the metastatic niche, as well as counter tumor progression and metastatic growth.